Abstract
There is limited information of level of drug resistance to first-line and second line anti-tuberculosis agents in treatment naïve pulmonary tuberculosis (PTB) patients from the Indian region. Therefore, the present prospective study was conducted to determine the antimicrobial susceptibility to first-line and second line anti-TB drug resistance in such patients. Sputum samples from consecutive treatment naïve PTB cases registered in Lala Ram Sarup (LRS) district, under RNTCP containing 12 Directly Observed Treatment Centre’s (DOTS), were enrolled using cluster sampling technology. A total of 453 samples were received from July 2011 to June 2012. All samples were cultured on solid medium followed by drug susceptibility to first and second line anti-tubercular drugs as per RNTCP guidelines.
Primary multi-drug resistance (MDR) was found to be 18/453; (4.0%). Extensively drug resistance (XDR) was found in one strain (0.2%), which was found to be resistant to other antibiotics. Data of drug resistant tuberculosis among treatment naïve TB patients are lacking in India. The presence of XDR-TB and high MDR-TB in small population studied, calls for conducting systematic multi-centric surveillance across the country.
Article PDF
Avoid common mistakes on your manuscript.
References
Dooley SW, Jarvis WR, Martone WJ, Snider Jr D. Multidrug-resistant tuberculosis. Ann Intern Med 1992;117:257–9.
World Health Organization. Global Tuberculosis Report, Geneva, Switzerland, WHO Report 2013 WHO/HTM/TB Geneva, Switzerland, 2013.
Shah NS, Wright A, Bai GH, Barerra L, Boulahbal F. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2014;13:30–7.
McGrath M, Pittius Gey van NC, Van Helden PD, Warren RM, Warner DF. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2014;69:292–302.
Sharma SK, Kaushik G, Jha B. Prevalence of multi-drug resistant tuberculosis among newly diagnosed cases of sputum positive pulmonary tuberculosis. Indian J Med Res 2011;133:308–11.
World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis: WHO Report 2009 WHO/HTM/TB Geneva, Switzerland, 2009.
Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Revised National Tuberculosis Control Programme, Module for laboratory technicians: RNTCP 2005, New Delhi, India.
Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Revised National Tuberculosis Control Programme, Manual of standard operating procedures of culture of Mycobacterium tuberculosis and drug susceptibility testing on solid medium: RNTCP 2009, New Delhi, India.
Shao Y, Yang D, Xu W, Lu W, Song H. Epidemiology of antituberculosis drug resistance in a Chinese population: current situation and challenges ahead. BMC Public Health 2011; 11: 110.
Alcaide J, Altet MN, Plans P, Parrón I, Folguera L. Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study. Tuber Lung Dis 1996;77:112–6.
Anamika G, Jitendra PM, Surya KS, Anil KG, Shampa A. Antitubercular drug resistance in four healthcare facilities in North India. J Health Popul Nutr 2011;29:583–92.
Chang SW, Pan WS, Beltran DL, Baldelomar LO, Solano MA, Friedland JS, et al. Gut harmones, appetite suppression and cachexia in patients with pulmonary TB. PLoS One 2013;8:545–64.
Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvo G. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health 2009;211:1–9.
Joseph MR, Shoby CT, Amma GR, Chauhan LS, Paramasivan CN. Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. Int J Tuberc Lung Dis 2007;11:439–43.
Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009;13:1154–60.
Paramasivan CN, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan PR. Surveillance of drug resistance in tuberculosis in two districts of south India. Int J Tuberc Lung Dis 2002;6:479–84.
Jain A, Mondal R, Prasad R, Singh K, Ahuja RC. Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian J Med Res 2008; 128: 300–6.
Jain NK, Chopra KK, Prasad G. Initial and acquired isoniazid and rifampicin resistance to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992; 39:12–4.
Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. Modeling of novel diagnostic strategies for active tuberculosis – a systematic review: current practices and recommendations. PLoS One 2014;9(10):e110558.
Myneedu VP, Visalakshi P, Verma AK, Behera D, Bhalla M. Prevalence of XDR TB cases – a retrospective study from a tertiary care TB hospital. Indian J Tuberc 2011;58:54–9.
Chakraborty N, De C, Bhattacharyya S, Mukherjee A, Santra S, Banerjee D, et al. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India. Trans R Soc Trop Med Hyg 2010;104:101–95.
Thomas A, Ramachandaran R, Rehaman F, Jaggarajamma K, Santha T, Selvakumar N, et al. Management of multidrug resistance tuberculosis in the field: tuberculosis Research Centre experience. Indian J Tuberc 2007;54: 117–24.
Mondal R, Jain A. Extensively drug resistant Mycobacterium tuberculosis, India. Emerg Infect Dis 2007;13:1429–31.
Michael JS, John TJ. Extensively drug-resistant tuberculosis in India: a review. Indian J Med Res 2012; 1(36):504–99.
Horsburg J. Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons. J Infect Dis 2008;198:1577–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
About this article
Cite this article
Myneedu, V.P., Singhal, R., Khayyam, K.U. et al. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi. J Epidemiol Glob Health 5, 365–373 (2015). https://doi.org/10.1016/j.jegh.2015.04.002
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jegh.2015.04.002